Recombinant CD19 (Inebilizumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA, FACS
宿主: Humanized
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all CD19 (Inebilizumab Biosimilar) products
- CD19 (Inebilizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Humanized
-
克隆类型
- 单克隆
-
标记
- This CD19 (Inebilizumab Biosimilar) antibody is un-conjugated
- 应用范围
- ELISA, Flow Cytometry (FACS)
- 原理
- Anti-CD19 (inebilizumab biosimilar) mAb
- 产品特性
- MEDI-551,Medi-551
- 纯化方法
- Purified from cell culture supernatant by affinity chromatography
- 质量等级
- Research Grade
- 亚型
- IgG1
-
-
- 应用备注
- Flow Cyt 1:100
- 说明
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Reconstitute with deionized water
- 缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- 有效期
- 12 months
-
- 抗原
- CD19 (Inebilizumab Biosimilar)
- Abstract
- CD19 (Inebilizumab Biosimilar) 产品
- 物质类
- Biosimilar
- 背景
- Synonyms: CD19,B4,CVID3,MGC12802
- 基因ID
- 930
- UniProt
- P15391
-
You are here:
